文献速递外周动脉疾病

充血性心力衰竭对下肢血运重建中期结局的影响

Impact of congestive heart failure on mid-term outcomes after lower extremity revascularization for peripheral artery disease.
PubMed 文献 · J Vasc Surg · 2025-05-20

基于SVS VQI-VISION医保链接数据库,纳入2010至2018年因外周动脉疾病接受外周血管介入或下肢旁路术的患者,按充血性心力衰竭严重程度分为中度/重度组与无/无症状/轻度组,分析3年死亡、大截肢和再干预。结果显示心力衰竭严重程度是30天和中期死亡的强预测因子,但未显著影响中期大截肢或总体截肢。

要点

  • 心力衰竭严重程度是外周动脉疾病血运重建后30天和中期死亡的强预测因子。
  • 心力衰竭严重程度未显著影响中期大截肢或总体截肢。
  • 中度至重度心力衰竭的间歇性跛行患者应强烈考虑保守治疗。

核心结论

  • 心力衰竭严重程度是外周动脉疾病患者接受外周血管介入或下肢旁路术后30天和中期死亡的强预测因子。
  • 心力衰竭严重程度未显著影响中期大截肢或总体截肢。
  • 中度至重度心力衰竭的间歇性跛行患者应强烈考虑保守治疗。
  • 评估术前风险、决定血运重建策略和规划术后护理时,应基于个体化原则考虑按症状状态划分的心力衰竭严重程度。

研究设计与样本

  • 回顾性队列研究,使用SVS VQI-VISION医保链接数据库,纳入2010至2018年因外周动脉疾病接受外周血管介入或下肢旁路术的患者。
  • 按心力衰竭严重程度分组:1组为中/重度,2组为无/无症状/轻度。
  • 分别分析慢性肢体威胁性缺血和间歇性跛行患者,主要终点为3年死亡、大截肢和再干预,并进行倾向性匹配。

主要发现

  • 共纳入62,129例外周动脉疾病合并心力衰竭患者,其中47,457例接受外周血管介入(间歇性跛行n=19,741;慢性肢体威胁性缺血n=27,716),14,672例接受下肢旁路术(间歇性跛行n=3,688;慢性肢体威胁性缺血n=10,984)。
  • 倾向性匹配在418例间歇性跛行患者、1,516例接受外周血管介入的慢性肢体威胁性缺血患者和378例接受下肢旁路术的慢性肢体威胁性缺血患者中进行。
  • 1组中接受下肢旁路术的间歇性跛行患者极少(n=52),该组未进一步分析。
  • 中位年龄71岁;约70%为男性、白人,并患有冠状动脉疾病。
  • Kaplan-Meier分析显示,慢性肢体威胁性缺血患者接受外周血管介入和下肢旁路术后以及间歇性跛行患者接受外周血管介入后,3年生存率均以2组更优。

临床怎么用

  • 作者认为,中度至重度心力衰竭的间歇性跛行患者应强烈考虑保守治疗。
  • 作者认为,评估术前风险、决定血运重建策略和规划术后护理时,应基于个体化原则考虑按症状状态划分的心力衰竭严重程度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Congestive heart failure (CHF) and peripheral artery disease (PAD) often coexist, with worse outcomes in patients undergoing PAD procedures. We investigated the impact of CHF on mid-term mortality and postoperative outcomes after PAD interventions. METHODS: Patients in the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI)-Vascular Implant Surveillance and Interventional Outcomes Network (VISION) Medicare-linked database undergoing peripheral vascular interventions (PVIs) and lower extremity bypass (LEB) for PAD between 2010 and 2018 were grouped by CHF severity: Group 1, moderate/severe; and Group 2, none/asymptomatic/mild. We analyzed patients with chronic limb-threatening ischemia (CLTI) and intermittent claudication (IC) separately. Primary endpoints were 3-year death, major amputation, and reintervention. We performed propensity matching between groups. Kaplan-Meier, Cox proportional hazards, and Fine-Gray competing risk models were used to compare outcomes. RESULTS: Of 62,129 patients with PAD and CHF, 47,457 underwent PVI (IC, n = 19,741; CLTI, n = 27,716) and 14,672 underwent LEB (IC, n = 3688; CLTI, n = 10,984). Propensity matching was performed on 418 claudicants, 1516 patients with CLTI undergoing PVI, and 378 patients with CLTI undergoing LEB. There were very few claudicants (n = 52) in Group 1 who underwent LEB, and this group was not analyzed further. The median age was 71 years; around 70% were male, White, and had coronary artery disease. On Kaplan-Meier analyses, 3-year survival favored Group 2 after both PVI and LEB for CLTI and PVI for IC. After PVI for CLTI, Group 1 had worse freedom from major amputation. On Cox regression analyses, Group 1 was associated with worse 3-year mortality after both PVI and LEB for CLTI and PVI for IC. Fine-Gray analysis for patients with CLTI showed a lower reintervention rate in Group 1 after LEB with no difference in reintervention after PVI, and no difference in major amputation after PVI or LEB. Group 1 had a lower mortality risk at 3 years for patients with CLTI after LEB (65.3%) compared with PVI (70.5%) and a similar risk of reintervention and major amputation. CONCLUSIONS: CHF severity is a strong predictor of 30-day and mid-term mortality after both PVI and LEB for PAD. CHF severity did not significantly affect mid-term major or overall amputation. Conservative management should be strongly considered for claudicants with moderate to severe CHF. CHF severity by symptom status should be considered on an individualized basis when assessing preoperative risk, deciding revascularization strategy, and planning postoperative care.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Lin B, Solano A, Timaran CH, et al. Impact of congestive heart failure on mid-term outcomes after lower extremity revascularization for peripheral artery disease. J Vasc Surg. 2025. PMID: 40404024. doi:10.1016/j.jvs.2025.05.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。